Trump Links Autism to Tylenol During Pregnancy: Experts Warn Evidence Remains Uncertain, Urge More Research

Spread the Message

Read Time:4 Minute, 20 Second

On September 22, 2025, President Donald Trump and U.S. Health Secretary Robert F. Kennedy Jr. announced a purported link between Tylenol (acetaminophen) use during pregnancy and increased risk of autism in children—a claim fiercely disputed by medical experts, who highlight the lack of definitive scientific evidence and caution against spreading fear among expectant families.

Key Findings and Developments

President Trump’s White House statement suggested that the growing rates of autism in the United States may be “artificially induced” by over-the-counter medications such as Tylenol, and hinted at a potential role for common vaccines, reigniting longstanding controversies over autism causation.

This announcement triggered a sharp decline in Kenvue’s stock, Tylenol’s manufacturer, dropping 5.5% in a single day and 17% for the month as investors responded to heightened public scrutiny.

Research into the causes of autism is ongoing. The U.S. National Institutes of Health recently allocated $50 million in grants to investigate environmental and genetic factors, as well as potential therapies. However, multiple leading autism researchers stress that the evidence cited by officials does not prove Tylenol causes autism and that substantial, well-conducted studies are still needed.

Expert Perspectives

Medical authorities and independent experts widely disagree with the administration’s claims. Dr. Alison Singer, President of the Autism Science Foundation, noted that “overwhelming evidence supports a genetic basis for autism,” though researchers continue to study environmental influences.

James Cusack, Chief Executive of Autistica, a UK autism research advocacy group, emphasized: “There is no definitive evidence to suggest that paracetamol (acetaminophen) use in mothers is a cause of autism, and when you see any associations, they are very, very small”.

Dr. David Mandell, Professor of Psychiatry at the University of Pennsylvania, told Scientific American: “The evidence [from a handful of studies] was really mixed, and the effects were really small,” underscoring that acetaminophen remains one of the few pain relievers considered safe in pregnancy if used moderately and when medically necessary.

The American College of Obstetricians and Gynecologists (ACOG) reaffirmed its guidance: “Despite recent unfounded claims, there’s no clear evidence linking prudent use [of Tylenol] to issues with fetal development. Acetaminophen can be used in moderation, and after consulting your doctor”.

Context and Background

Autism is a complex neurodevelopmental disorder characterized by differences in social communication, interaction, and behaviors. Prevalence rates have risen globally due to broader diagnostic criteria and increased awareness, but causes remain multifactorial, involving both genetic and environmental elements.

Twenty-seven studies reviewed by Ann Bauer, an epidemiologist, found “a strong and consistent association between prenatal acetaminophen use and offspring diagnoses of autism and ADHD,” but experts highlight that association does not equal causation, and observational studies are subject to confounding factors.

Despite the surge in autism diagnoses in the past twenty years, acetaminophen usage among pregnant women has remained stable, suggesting other factors may be involved.

The Trump administration also promoted leucovorin—a form of folinic acid traditionally used in cancer and anemia therapy—as a possible autism treatment, which experts say is premature without rigorous clinical trials.

Implications for Public Health

The administration’s statements may influence public perceptions and health decisions regarding commonly used medications. Experts caution that pregnant individuals should not discontinue acetaminophen use based on unsupported claims, as unmanaged fever and pain itself pose risks during pregnancy.

Medical professionals urge expecting parents to consult qualified obstetricians before making changes to their medication routines and to rely on established evidence, not headlines.

Counterarguments and Limitations

Observational studies suggesting an association between Tylenol and autism are limited by confounding variables, such as maternal illness, stress, or genetics.
None of the major health authorities, including NIH, CDC, or World Health Organization, have endorsed a causal link. Most emphasize that current evidence remains inconclusive and recommend acetaminophen as a first-line pain and fever relief during pregnancy when medically necessary.
Experts warn that promoting unproven links may provoke unnecessary fear and guilt among expectant mothers and potentially distract from genuine research advances.

Practical Implications for Readers

Always speak to a healthcare provider before changing medication use during pregnancy.
Acetaminophen is still considered generally safe when used as directed by your doctor.
Avoid panic or misinformation; seek advice from reputable sources such as your OB-GYN, pediatrician, or government health agencies.
Understand that autism’s causes are complex and research is ongoing—no single medication or factor has yet been confirmed as a root cause.

Diverse Perspectives

Some in the autism community voiced concern that these claims could further stigmatize families affected by autism. Advocacy groups highlight the need for supportive public discourse, focused on inclusion and factual information, rather than speculation.

Medical Disclaimer

“Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.”